Fibronectin in blood invokes the development of focal segmental glomerulosclerosis in mouse model

Abstract

We infer that FN in blood acts as an initiator of the development of FSGS in this mouse model. In addition, serum and urine FN proteins could serve as useful biomarkers for monitoring the progression of FSGS.